HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

ISRKAKGWFYRHHYESTHPR Vif(31-50) human epitope
  RKAKGWFYRHHYESTHPR Vif(33-50) human epitope
  GKAKGWFYRHHYESTHPR Vif(33-50) human epitope
          RHHYESRHPKVSSEVHI Vif(41-57) B*15:10 human epitope
          RHHYESRHPKVSSEVyI Vif(41-57) observed variant
          RHHYESRHPiVSSEVyI Vif(41-57) observed variant
          RHHYESRHPKVSSEVHI Vif(41-57) B*15:10 human epitope
               SPHPRISSEV Vif(46-55) B*07 human, transgenic mouse epitope
               StHPRISSEV Vif(46-55) susceptible form
                 HPRVSSEVHI Vif(48-57) B*07 human epitope
                 HPRISSEVHI Vif(48-57) B*07 human, transgenic mouse epitope
                 HPkISSEVHI Vif(48-57) non-susceptible form
                 HPRvSSEVHI Vif(48-57) non-susceptible form
                 HPRVSSEVHI Vif(48-57) B*07:02 human epitope
                 HPRVSSEVHI Vif(48-57) B*07:02 human epitope
                 HPRVSSEVHI Vif(48-57) B*07:02 human epitope
                 HPRISSEVHI Vif(48-57) B*07:02 human epitope
                 HPRvSSEVHI Vif(48-57) diminished response; escape documented in this paper; non-susceptible form
                 HPkISSEVHI Vif(48-57) diminished response; escape documented in this paper; non-susceptible form
                 HPRVSSEVHI Vif(48-57) B*07:02 human epitope
                 HPRISSEVHI Vif(48-57) B*07:02 human epitope
                 HPkISSEVHI Vif(48-57) subtype-specific non-susceptible form
                 HPRVSSEVHI Vif(48-57) B*18 human epitope
                 HPRVSSEVHI Vif(48-57) B*27 human epitope
                 HPKVSSEVHI Vif(48-57) B*42 human epitope
                 HPKVSSEVHv Vif(48-57) observed variant
                 HPKVSSEiHI Vif(48-57) observed variant
                 HPKVSSEVHt Vif(48-57) observed variant
                 nPKVSSEVHI Vif(48-57) observed variant
                 HPKiSSEVHI Vif(48-57) observed variant
                 HPrVSSEVHI Vif(48-57) observed variant
                 HPKVSSEVHI Vif(48-57) B*42:01 human epitope
                 HPKVSSEVHI Vif(48-57) B*42:01 human epitope
                 HPKVSSEVHI Vif(48-57) B*42:01 human epitope
                 HPKVSSEVHI Vif(48-57) B*42:01 human epitope
                 HPKVSSEVHI Vif(48-57) B*42:01 human epitope
                 nPKVSSEVHI Vif(48-57) escape documented in this paper; observed variant
                 HPRVSSEVHI Vif(48-57) B*42:01 human epitope
                 HPRVSSEVHI Vif(48-57) B*51 human epitope
                 HPRISSEVHI Vif(48-57) B7 human epitope
                 HPkISSEVHI Vif(48-57) susceptible form
                 HPRISSEVHI Vif(48-57) B7 human epitope
                 HPKISSEVHI Vif(48-57) B7 human epitope
                 HPRVSSEVHI Vif(48-57) B7 human epitope
                 HPRISSEVHI Vif(48-57) B7 human epitope
                 HPRVSSEVHI Vif(48-57) B7 human epitope
                 HPKISSEVHI Vif(48-57) B7 human epitope
                 HPRISSEVHI Vif(48-57) B7 human epitope
                 HPKVSSEVHI Vif(48-57) human epitope
                 HPRVSSEVHI Vif(48-57) human epitope
                 HPKVSSEVHIA Vif(48-58) B*42:01 human epitope
                 xPKVSSEVHIa Vif(48-58) escape documented in this paper
                    ISSEVHIPLGDARLVITTYW Vif(51-70) human epitope
                       EVHIPLGDAR Vif(54-63) A*68:01 human epitope
                       EVHIPLGeAR Vif(54-63) observed variant
                       EVHIPLGDAk Vif(54-63) observed variant
                       EVHIPvGDAR Vif(54-63) observed variant
                       EVHIPLGDgR Vif(54-63) observed variant
                       EVHIPLGEAR Vif(54-63) A*68:01 human epitope
                       EVHIPLGEAk Vif(54-63) observed variant
                       aVHIPLGEAi Vif(54-63) observed variant
                       EVHIPLGEAR Vif(54-63) A*68:01 human epitope
                         HIPLGEARLVIKTYWGL Vif(56-72) C*12 human epitope
                         HIPLGEARLVIKTYWGL Vif(56-72) human epitope
                          IPLGEAKLV Vif(57-65) B7 human epitope
                          IPLGDAKLII Vif(57-66) A*30 human epitope
                          IPLGDAKLII Vif(57-66) A*74 human epitope
                          IPLGDARLVI Vif(57-66) B*07 human, transgenic mouse epitope
                          IPLGDARLVv Vif(57-66) susceptible form
                          IPLGDAKLII Vif(57-66) B*07 human epitope
                          IPLGDAKLII Vif(57-66) B*18 human epitope
                          IPLGDAKLII Vif(57-66) B*51 human epitope
                          IPLGDALKII Vif(57-66) B*51 human epitope
                          IPLGDAKLII Vif(57-66) B*51 human epitope
                          IPLGDAKLII Vif(57-66) B51 human epitope
                          IPLGDARLVI Vif(57-66) B7 human epitope
                          IPLGDAKLII Vif(57-66) B*81 human epitope
                          IPLGDAKLII Vif(57-66) C*14 human epitope
                          IPLGDAKLII Vif(57-66) human epitope
                          IPLGDAKLVITTYWG Vif(57-71) B*51 epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health